respiratory syncytial virus

A doctor vaccinates an infant against respiratory syncytial virus (RSV) in a treatment room of her paediatric practice.Swen Pförtner | Picture Alliance | Getty ImagesThe Centers for Disease Control and Prevention on Friday recommended …

By LAURAN NEERGAARD - AP Medical Writer WASHINGTON (AP) — Updated COVID-19 vaccines are coming soon, just in time to pair them with flu shots. And this fall, the first vaccines for another…

By LAURAN NEERGAARD - AP Medical Writer WASHINGTON (AP) — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the…

Budrul Chukrut | Lightrocket | Getty ImagesGlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company's new RSV vaccine to start off slower than it did for its blockbuster shingles shot.But she is confident that…

Respiratory syncytial virus vial.Manjurul | Istock | Getty ImagesThe Centers for Disease Control and Prevention on Thursday recommended that adults ages 60 and above receive a single dose of RSV vaccines from Pfizer and GSK after consulting…

Respiratory syncytial virus vial.Manjurul | Istock | Getty ImagesVaccinating one million adults ages 65 and above with a single RSV shot from Pfizer or GSK may prevent thousands of hospitalizations over two seasons of the virus, according…

A health worker prepares a flu vaccine shot before administering it to a local resident in Los Angeles, the United States, on Dec. 17, 2022.Xinhua News Agency | Getty ImagesAn advisory committee to the Centers for Disease Control and…

Respiratory syncytial virus viral vaccine under research.Hailshadow | Istock | Getty ImagesGlaxoSmithKline on Wednesday said its vaccine to protect adults ages 60 and older from respiratory syncytial virus, or RSV, remained effective across…

Respiratory syncytial virus - viral vaccine under researchHailshadow | Istock | Getty ImagesPfizer's vaccine that protects adults ages 60 and older from respiratory syncytial virus was slightly less effective after 18 months, according to…

Luis Alvarez | Digitalvision | Getty ImagesThe Food and Drug Administration on Wednesday approved a vaccine made by Pfizer that protects adults ages 60 and older from respiratory syncytial virus, a common pathogen that kills and…